Måns Agrup
Impact in
- Radiation top 2%
- Advanced Radiotherapy Techniques
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Radiation Therapy and Dosimetry
Papers in
-
- Prostate Cancer Diagnosis and Treatment 5
- Prostate Cancer Treatment and Research 4
- Radiation Therapy and Dosimetry 3
- Genetics 5
- Glioma Diagnosis and Treatment 5
- Co-authors
- Per Nilsson (6 shared papers)David Norman (3 shared papers)Claes Ginman (5 shared papers)Anders Widmark (5 shared papers)Jon Kindblom (4 shared papers)Elisabeth Kjellén (4 shared papers)Bengt Johansson (4 shared papers)Adalsteinn Gunnlaugsson (5 shared papers)
In The Last Decade
Måns Agrup
12 papers receiving 754 citations
Måns Agrup's Hit Papers
Peers
Comparison fields: 5 of 54
- Radiation 422
- Pulmonary and Respiratory Medicine 589
- Radiology, Nuclear Medicine and Imaging 193
- Oncology 105
- Cancer Research 57
Countries citing papers authored by Måns Agrup
This map shows the geographic impact of Måns Agrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Måns Agrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Måns Agrup more than expected).
Fields of papers citing papers by Måns Agrup
This network shows the impact of papers produced by Måns Agrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Måns Agrup. The network helps show where Måns Agrup may publish in the future.
Co-authors
The 25 scholars most cited alongside Måns Agrup, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial Hit paper breakdown → | 2019 | 559 |
| 2 | 2021 | 93 | |
| 3 | 2000 | 59 | |
| 4 | 2008 | 16 | |
| 5 | 2018 | 14 | |
| 6 | 2023 | 4 | |
| 7 | 2013 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2017 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2026 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About Måns Agrup
Måns Agrup is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Neurology, Radiation and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 759 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (5 papers), Glioma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (5 papers), Prostate Cancer Treatment and Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Advanced Radiotherapy Techniques (3 papers), Radiation Therapy and Dosimetry (3 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Radiation (422 citations), Pulmonary and Respiratory Medicine (589 citations), Radiology, Nuclear Medicine and Imaging (193 citations), Oncology (105 citations) and Cancer Research (57 citations). Måns Agrup has collaborated with scholars based in Sweden and Denmark. Frequent co-authors include Per Nilsson, David Norman, Claes Ginman, Anders Widmark, Jon Kindblom, Elisabeth Kjellén, Bengt Johansson, Adalsteinn Gunnlaugsson, Camilla Thellenberg‐Karlsson and Lars Franzén. Their work appears in journals such as Acta Oncologica, Radiotherapy and Oncology, The Lancet Oncology, Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.